Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSENT 3: Tenecteplase Regimens in Acute Myocardial Infarction
NCT02181985Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2000
- Primary completion
- Apr 2001
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of tenecteplase in ST elevation myocardial infarction (STEMI), sponsored by Boehringer Ingelheim. Started May 2000; status: completed.
02
Drugs
tenecteplase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02181985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181985.